CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 38 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,684,472 | -3.0% | 625,208 | -0.2% | 0.00% | -20.0% |
Q1 2024 | $9,982,474 | -4.1% | 626,253 | +1.2% | 0.01% | 0.0% |
Q4 2023 | $10,406,836 | +737.8% | 619,086 | +482.6% | 0.01% | +400.0% |
Q3 2023 | $1,242,144 | -90.4% | 106,257 | -88.9% | 0.00% | -85.7% |
Q2 2023 | $12,919,174 | -16.6% | 961,248 | +2.8% | 0.01% | -22.2% |
Q1 2023 | $15,497,956 | -23.0% | 934,738 | -13.6% | 0.01% | -25.0% |
Q4 2022 | $20,114,933 | +37.1% | 1,081,448 | -5.4% | 0.01% | +33.3% |
Q3 2022 | $14,673,000 | +4116.4% | 1,143,651 | +2205.9% | 0.01% | – |
Q2 2022 | $348,000 | -21.3% | 49,597 | -6.9% | 0.00% | – |
Q1 2022 | $442,000 | +10.5% | 53,283 | -9.9% | 0.00% | – |
Q4 2021 | $400,000 | +34.7% | 59,123 | +5.5% | 0.00% | – |
Q3 2021 | $297,000 | -10.5% | 56,022 | -3.1% | 0.00% | – |
Q2 2021 | $332,000 | +6.4% | 57,815 | -14.5% | 0.00% | – |
Q1 2021 | $312,000 | +27.3% | 67,656 | -8.0% | 0.00% | – |
Q4 2020 | $245,000 | +42.4% | 73,562 | +27.2% | 0.00% | – |
Q3 2020 | $172,000 | -28.3% | 57,850 | +11.1% | 0.00% | – |
Q2 2020 | $240,000 | -87.2% | 52,052 | -89.3% | 0.00% | -100.0% |
Q1 2020 | $1,876,000 | +2.2% | 487,307 | -0.5% | 0.00% | +100.0% |
Q4 2019 | $1,835,000 | +1156.8% | 489,579 | +1650.4% | 0.00% | – |
Q3 2019 | $146,000 | -55.8% | 27,970 | -67.5% | 0.00% | – |
Q2 2019 | $330,000 | -47.7% | 86,112 | -30.7% | 0.00% | – |
Q1 2019 | $631,000 | +161.8% | 124,260 | -1.4% | 0.00% | – |
Q4 2018 | $241,000 | -89.9% | 126,064 | -80.0% | 0.00% | -100.0% |
Q3 2018 | $2,379,000 | +112.8% | 629,858 | +75.6% | 0.00% | – |
Q2 2018 | $1,118,000 | -38.7% | 358,716 | -53.0% | 0.00% | -100.0% |
Q1 2018 | $1,825,000 | -29.5% | 763,976 | +15.3% | 0.00% | -50.0% |
Q4 2017 | $2,589,000 | +130.3% | 662,502 | +48.4% | 0.00% | +100.0% |
Q3 2017 | $1,124,000 | -37.6% | 446,407 | -31.6% | 0.00% | 0.0% |
Q2 2017 | $1,800,000 | +576.7% | 652,611 | +377.1% | 0.00% | – |
Q1 2017 | $266,000 | +1562.5% | 136,788 | +811.9% | 0.00% | – |
Q3 2016 | $16,000 | -93.5% | 15,000 | -95.7% | 0.00% | – |
Q2 2016 | $245,000 | -52.0% | 345,445 | -21.0% | 0.00% | – |
Q1 2016 | $510,000 | -41.5% | 437,146 | +22.6% | 0.00% | -100.0% |
Q4 2015 | $872,000 | -60.7% | 356,430 | -51.8% | 0.00% | -50.0% |
Q3 2015 | $2,218,000 | +32.4% | 739,904 | +82.3% | 0.00% | +100.0% |
Q2 2015 | $1,675,000 | +59.7% | 405,901 | +67.4% | 0.00% | 0.0% |
Q1 2015 | $1,049,000 | +48.6% | 242,493 | +2.0% | 0.00% | – |
Q4 2014 | $706,000 | -10.5% | 237,800 | 0.0% | 0.00% | – |
Q3 2014 | $789,000 | +526.2% | 237,800 | +375.6% | 0.00% | – |
Q2 2014 | $126,000 | +11.5% | 50,000 | 0.0% | 0.00% | – |
Q1 2014 | $113,000 | -21.5% | 50,000 | +5.2% | 0.00% | – |
Q3 2013 | $144,000 | – | 47,529 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 17,875,655 | $94,920,000 | 9.39% |
TANAKA CAPITAL MANAGEMENT INC | 283,334 | $1,505,000 | 4.86% |
GABLES CAPITAL MANAGEMENT INC. | 490,564 | $2,606,000 | 1.84% |
MANGROVE PARTNERS IM, LLC | 2,508,838 | $13,322,000 | 1.61% |
Broadfin Capital, LLC | 880,303 | $4,674,000 | 0.86% |
Atom Investors LP | 1,012,355 | $5,376,000 | 0.37% |
Capital Impact Advisors, LLC | 179,868 | $948,000 | 0.36% |
KNOTT DAVID M | 151,415 | $804,000 | 0.34% |
EMERALD ADVISERS, LLC | 1,175,958 | $6,244,000 | 0.29% |
CADENCE CAPITAL MANAGEMENT LLC | 371,075 | $1,970,000 | 0.28% |